Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.5 GBX | -0.47% | +1.43% | -8.97% |
Apr. 26 | UK companies in 'significant' distress up 30% in Q1 - Begbies Traynor | AN |
Feb. 26 | Begbies trading in line; Probiotix inks partnership | AN |
Valuation
Fiscal Period: April | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 68.61 | 132.8 | 179.6 | 181 | 202.4 | 166.8 | - | - |
Enterprise Value (EV) 1 | 74.61 | 135.6 | 176.6 | 176.3 | 199.4 | 167.9 | 164 | 155.8 |
P/E ratio | 28.6 x | 149 x | 1,190 x | -393 x | 72.8 x | 266 x | 26.6 x | 15.9 x |
Yield | 4.33% | 2.69% | 2.52% | 2.97% | 2.9% | 3.76% | 3.93% | 4.1% |
Capitalization / Revenue | 1.14 x | 1.88 x | 2.14 x | 1.65 x | 1.66 x | 1.25 x | 1.17 x | 1.12 x |
EV / Revenue | 1.24 x | 1.92 x | 2.11 x | 1.6 x | 1.64 x | 1.25 x | 1.15 x | 1.04 x |
EV / EBITDA | 8.98 x | 12.3 x | 13.3 x | 7.91 x | 7.95 x | 6.06 x | 5.62 x | 5.09 x |
EV / FCF | 11.8 x | 14.1 x | 14.7 x | 12.6 x | 34.2 x | 13.6 x | 9.94 x | 9.38 x |
FCF Yield | 8.48% | 7.11% | 6.82% | 7.94% | 2.92% | 7.37% | 10.1% | 10.7% |
Price to Book | - | - | 1.83 x | 2.16 x | 2.52 x | 2.09 x | 2.09 x | 1.97 x |
Nbr of stocks (in thousands) | 114,351 | 127,702 | 150,953 | 153,402 | 154,512 | 156,637 | - | - |
Reference price 2 | 0.6000 | 1.040 | 1.190 | 1.180 | 1.310 | 1.065 | 1.065 | 1.065 |
Announcement Date | 7/9/19 | 7/21/20 | 7/20/21 | 7/19/22 | 7/11/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: April | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 60.06 | 70.5 | 83.83 | 110 | 121.8 | 133.9 | 142.3 | 149.5 |
EBITDA 1 | 8.313 | 11.05 | 13.24 | 22.28 | 25.07 | 27.7 | 29.2 | 30.6 |
EBIT 1 | 7.553 | 10.12 | 12.39 | 18.59 | 21.82 | 23.93 | 25.45 | 27.18 |
Operating Margin | 12.58% | 14.35% | 14.78% | 16.9% | 17.91% | 17.87% | 17.88% | 18.18% |
Earnings before Tax (EBT) 1 | 3.526 | 2.884 | 1.907 | 4.049 | 5.985 | 5.775 | 13.87 | 17.9 |
Net income 1 | 2.434 | 0.931 | 0.153 | -0.5 | 2.911 | 1.35 | 8.033 | 11.6 |
Net margin | 4.05% | 1.32% | 0.18% | -0.45% | 2.39% | 1.01% | 5.65% | 7.76% |
EPS 2 | 0.0210 | 0.007000 | 0.001000 | -0.003000 | 0.0180 | 0.004000 | 0.0400 | 0.0670 |
Free Cash Flow 1 | 6.327 | 9.639 | 12.04 | 14 | 5.827 | 12.37 | 16.5 | 16.6 |
FCF margin | 10.53% | 13.67% | 14.37% | 12.73% | 4.78% | 9.23% | 11.6% | 11.11% |
FCF Conversion (EBITDA) | 76.11% | 87.25% | 91% | 62.85% | 23.24% | 44.65% | 56.51% | 54.25% |
FCF Conversion (Net income) | 259.94% | 1,035.34% | 7,871.9% | - | 200.17% | 916.05% | 205.39% | 143.1% |
Dividend per Share 2 | 0.0260 | 0.0280 | 0.0300 | 0.0350 | 0.0380 | 0.0400 | 0.0419 | 0.0436 |
Announcement Date | 7/9/19 | 7/21/20 | 7/20/21 | 7/19/22 | 7/11/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: April | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 33.78 | - | - | - | - | - | - | - | 68 |
EBITDA | - | - | - | - | - | - | - | - | - |
EBIT 1 | - | - | - | - | - | - | - | - | 13.55 |
Operating Margin | - | - | - | - | - | - | - | - | 19.93% |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - |
Net income | - | - | - | - | - | - | 3.721 | 1.219 | - |
Net margin | - | - | - | - | - | - | - | - | - |
EPS | 0.0100 | - | - | - | - | - | 0.0230 | 0.008000 | - |
Dividend per Share | 0.009000 | 0.0190 | 0.0100 | 0.0200 | 0.0110 | 0.0200 | - | - | - |
Announcement Date | 12/10/19 | 7/21/20 | - | 7/20/21 | - | 7/19/22 | 12/13/22 | 12/11/23 | - |
Balance Sheet Analysis
Fiscal Period: April | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 6 | 2.8 | - | - | - | 1.08 | - | - |
Net Cash position 1 | - | - | 3 | 4.7 | 3 | - | 2.8 | 11 |
Leverage (Debt/EBITDA) | 0.7218 x | 0.2534 x | - | - | - | 0.0388 x | - | - |
Free Cash Flow 1 | 6.33 | 9.64 | 12 | 14 | 5.83 | 12.4 | 16.5 | 16.6 |
ROE (net income / shareholders' equity) | 9.3% | - | - | 16.6% | 19.4% | 20.1% | 21.9% | 23.2% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | 0.6500 | 0.5500 | 0.5200 | 0.5100 | 0.5100 | 0.5400 |
Cash Flow per Share 2 | - | - | 0.0900 | 0.0600 | 0.0400 | 0.0900 | 0.1300 | 0.1200 |
Capex 1 | - | - | 1 | 1.06 | 0.99 | 1.15 | 1.3 | 1.73 |
Capex / Sales | - | - | 1.19% | 0.97% | 0.81% | 0.86% | 0.91% | 1.16% |
Announcement Date | 7/9/19 | 7/21/20 | 7/20/21 | 7/19/22 | 7/11/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.97% | 209M | |
+11.84% | 68.39B | |
+14.09% | 18.61B | |
+21.12% | 13.54B | |
+8.00% | 13.22B | |
+16.72% | 10.03B | |
-28.16% | 6.2B | |
-9.71% | 5.65B | |
-1.25% | 5.05B | |
-3.89% | 4.82B |
- Stock Market
- Equities
- BEG Stock
- Financials Begbies Traynor Group plc